Fundraising Fox
큐어버스
Seoul, KR · 1 known investors
Find your way into 큐어버스
Sign up to see every warm intro you have to 큐어버스
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 큐어버스 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cureverse is a global biotech company that discovers novel small-molecule drugs based on its proprietary "Right Structure" concept, targeting intractable diseases including dementia, cancer, and inflammatory conditions. The company aims to provide sustainable therapeutic solutions with improved efficacy, safety, and drug-like properties for patients with difficult-to-treat neurological and systemic diseases.
Founders & leadership
Investors · 1
Frequently asked questions
- What does 큐어버스 do?
- Cureverse is a global biotech company that discovers novel small-molecule drugs based on its proprietary "Right Structure" concept, targeting intractable diseases including dementia, cancer, and inflammatory conditions. The company aims to provide sustainable therapeutic solutions with improved efficacy, safety, and drug-like properties for patients with difficult-to-treat neurological and systemic diseases.
- Who founded 큐어버스?
- 큐어버스 was founded by Jungwook Chin.
- Who are 큐어버스's investors?
- 큐어버스's investors include Solidus Investment.
- Where is 큐어버스 headquartered?
- 큐어버스 is headquartered in Seoul, KR.